These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30012197)

  • 1. Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients.
    Suo C; Deng W; Vu TN; Li M; Shi L; Pawitan Y
    Biol Direct; 2018 Jul; 13(1):14. PubMed ID: 30012197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data.
    Łastowska M; Viprey V; Santibanez-Koref M; Wappler I; Peters H; Cullinane C; Roberts P; Hall AG; Tweddle DA; Pearson AD; Lewis I; Burchill SA; Jackson MS
    Oncogene; 2007 Nov; 26(53):7432-44. PubMed ID: 17533364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.
    Wolf M; Korja M; Karhu R; Edgren H; Kilpinen S; Ojala K; Mousses S; Kallioniemi A; Haapasalo H
    BMC Cancer; 2010 May; 10():181. PubMed ID: 20444257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
    Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
    Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma.
    Chicard M; Boyault S; Colmet Daage L; Richer W; Gentien D; Pierron G; Lapouble E; Bellini A; Clement N; Iacono I; Bréjon S; Carrere M; Reyes C; Hocking T; Bernard V; Peuchmaur M; Corradini N; Faure-Conter C; Coze C; Plantaz D; Defachelles AS; Thebaud E; Gambart M; Millot F; Valteau-Couanet D; Michon J; Puisieux A; Delattre O; Combaret V; Schleiermacher G
    Clin Cancer Res; 2016 Nov; 22(22):5564-5573. PubMed ID: 27440268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmental chromosome aberrations converge on overexpression of mitotic spindle regulatory genes in high-risk neuroblastoma.
    Ooi WF; Re A; Sidarovich V; Canella V; Arseni N; Adami V; Guarguaglini G; Giubettini M; Scaruffi P; Stigliani S; Lavia P; Tonini GP; Quattrone A
    Genes Chromosomes Cancer; 2012 Jun; 51(6):545-56. PubMed ID: 22337647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.
    Bigagli E; De Filippo C; Castagnini C; Toti S; Acquadro F; Giudici F; Fazi M; Dolara P; Messerini L; Tonelli F; Luceri C
    Cell Oncol (Dordr); 2016 Dec; 39(6):545-558. PubMed ID: 27709558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
    Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma.
    Fransson S; Östensson M; Djos A; Javanmardi N; Kogner P; Martinsson T
    Int J Oncol; 2016 Mar; 48(3):1103-16. PubMed ID: 26794043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, China.
    Zhang Y; Xue Q; Pan G; Meng QH; Tuo X; Cai X; Chen Z; Li Y; Huang T; Duan X; Duan Y
    PLoS One; 2017; 12(1):e0169098. PubMed ID: 28056099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
    Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
    Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
    Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
    Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
    Chen QR; Bilke S; Wei JS; Whiteford CC; Cenacchi N; Krasnoselsky AL; Greer BT; Son CG; Westermann F; Berthold F; Schwab M; Catchpoole D; Khan J
    BMC Genomics; 2004 Sep; 5():70. PubMed ID: 15380028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.
    Ackermann S; Kocak H; Hero B; Ehemann V; Kahlert Y; Oberthuer A; Roels F; Theißen J; Odenthal M; Berthold F; Fischer M
    BMC Cancer; 2014 Nov; 14():840. PubMed ID: 25406647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic stratification of neuroblastoma for treatment tailoring.
    Jeison M; Yaniv I; Ash S
    Future Oncol; 2011 Sep; 7(9):1087-99. PubMed ID: 21919696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalance between genomic gain and loss identifies high-risk neuroblastoma patients with worse outcomes.
    Fernández-Blanco B; Berbegall AP; Martin-Vañó S; Castel V; Navarro S; Noguera R
    Neoplasia; 2021 Jan; 23(1):12-20. PubMed ID: 33190090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall genomic pattern is a predictor of outcome in neuroblastoma.
    Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
    J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement.
    Suman M; Löfgren M; Fransson S; Yousuf JI; Svensson J; Djos A; Martinsson T; Kogner P; Kling T; Carén H
    J Transl Med; 2024 Aug; 22(1):808. PubMed ID: 39217334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational compensation of genomic instability in neuroblastoma.
    Dassi E; Greco V; Sidarovich V; Zuccotti P; Arseni N; Scaruffi P; Tonini GP; Quattrone A
    Sci Rep; 2015 Sep; 5():14364. PubMed ID: 26399178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissection of the oncogenic MYCN transcriptional network reveals a large set of clinically relevant cell cycle genes as drivers of neuroblastoma tumorigenesis.
    Murphy DM; Buckley PG; Bryan K; Watters KM; Koster J; van Sluis P; Molenaar J; Versteeg R; Stallings RL
    Mol Carcinog; 2011 Jun; 50(6):403-11. PubMed ID: 21557326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.